Cargando…
Antiviral Therapy for Prevention of Perinatal Hepatitis B Virus Transmission Reduces the Incidence of Postpartum Hepatitis Flare
Background: Currently, there are few studies on the effect of prophylactic anti-hepatitis B virus (HBV) therapy (AVT) for mother-to-child transmission during pregnancy on postpartum hepatitis flare (PHF) and the risk factors for postpartum hepatitis flare in women with chronic hepatitis B infection....
Autores principales: | Quan, Min, Liu, Xiao-Min, Liu, Cong, Li, Wei, Xing, Hui-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293540/ https://www.ncbi.nlm.nih.gov/pubmed/35860799 http://dx.doi.org/10.1155/2022/7046955 |
Ejemplares similares
-
Antiviral Therapy for a Postpartum Flare in Women with Chronic HBV Infection Shortens the ALT Recovery Time and Reduces Hepatitis Re-Flare Rates within 4 years
por: Quan, Min, et al.
Publicado: (2022) -
Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus
por: Pan, Xingfei, et al.
Publicado: (2020) -
Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
por: Lu, Ying, et al.
Publicado: (2021) -
Postpartum Hepatic Flares in Immune-Tolerant Pregnant Patients with Chronic Hepatitis B Virus Infection
por: Song, Myeong Jun
Publicado: (2022) -
Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
por: Wang, Wenjun, et al.
Publicado: (2016)